Metaphedrine

Metaphedrine
Clinical data
Other names3-Methyl-N-methylamphetamine; 3-MMA; 3MMA; 3-Me-MA; Metaphedrine
Legal status
Legal status
Identifiers
  • N-methyl-1-(3-methylphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H17N
Molar mass163.264 g·mol−1
3D model (JSmol)
  • CC1=CC(=CC=C1)CC(C)NC
  • InChI=1S/C11H17N/c1-9-5-4-6-11(7-9)8-10(2)12-3/h4-7,10,12H,8H2,1-3H3
  • Key:CXVNKBVJDKMLOH-UHFFFAOYSA-N

Metaphedrine, or 3-methylmethamphetamine (3-MMA), is a methamphetamine derivative which has been sold as a designer drug, with the substance first encountered online in 2020 and reported in Sweden in 2021. It is a potent monoamine reuptake inhibitor and is thought to have psychostimulant effects. The drug was not active as a serotonin 5-HT2A receptor agonist.

See also

References

  1. ↑ "Metaphedrine - FDA Global Substance Registration System". Food and Drug Administration. March 4, 2026. Archived from the original on April 19, 2026. Retrieved 2026-04-19.
  2. ↑ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 12 July 2025). ISBN 978-92-9497-737-3.{{cite book}}: CS1 maint: DOI inactive as of July 2025 (link)
  3. 1 2 "3-MMA (3-Метилметамфетамин)". АИПСИН (in Russian). Retrieved 1 January 2026.
  4. 1 2 Stalberga D, Kronstrand R, Schranz B, van Zijl N, Karlman S, Aref S, et al. (July 2026). "Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5-HT2A receptor". Br J Pharmacol. doi:10.1111/bph.70587. PMID 42449077.